For companies in the healthcare, food, cosmetics, and pharmaceutical sectors, ANVISA compliance is not only a legal obligation, it is a safeguard against fines of up to R$ 1.5 million, bans, and irreparable damage to reputation. With inspections on the rise and new rules coming into effect in 2025, regulatory compliance has become a strategic pillar for business survival. In this article, we reveal the main mistakes that lead to fines and how to turn prevention into a competitive advantage.
What you will see on this blog:
According to ANVISA data, 80% of fines are due to avoidable failures. Learn about the main ones:
Inspections can occur at any time, triggered by reports, technical complaints, or monitoring programs. In 2025, ANVISA intensified the use of digital data cross-checking to target inspections.
Steps to avoid fines during inspections:
Key fact: Companies that conduct preventive audits reduce the incidence of fines by 70%.
If your company receives a tax assessment notice, it is essential to act quickly!
ATTENTION: Fines that are not contested within the deadline become final and may be registered as outstanding debt.
Turn fine prevention into a lever for growth. Stone Okamont offers integrated solutions for your company:
With Stone Okamont, you can turn regulatory requirements into market opportunities. Request an audit and discover how our personalized consulting services protect your business while optimizing results.
Request a quote here.